Bright Minds Biosciences Stock Market Value
| DRUG Stock | USD 38.59 3.26 9.23% |
| Symbol | Bright |
Bright Minds Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Return On Assets (0.29) | Return On Equity (0.52) |
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bright Minds 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bright Minds' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bright Minds.
| 07/05/2023 |
| 11/26/2024 |
If you would invest 0.00 in Bright Minds on July 5, 2023 and sell it all today you would earn a total of 0.00 from holding Bright Minds Biosciences or generate 0.0% return on investment in Bright Minds over 510 days. Bright Minds is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patie... More
Bright Minds Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bright Minds' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bright Minds Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.54 | |||
| Information Ratio | 0.1384 | |||
| Maximum Drawdown | 1470.96 | |||
| Value At Risk | (11.87) | |||
| Potential Upside | 34.65 |
Bright Minds Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bright Minds' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bright Minds' standard deviation. In reality, there are many statistical measures that can use Bright Minds historical prices to predict the future Bright Minds' volatility.| Risk Adjusted Performance | 0.1163 | |||
| Jensen Alpha | 28.66 | |||
| Total Risk Alpha | (2.90) | |||
| Sortino Ratio | 2.9 | |||
| Treynor Ratio | (0.78) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bright Minds' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bright Minds Biosciences Backtested Returns
Bright Minds is out of control given 3 months investment horizon. Bright Minds Biosciences secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15% return per unit of risk over the last 3 months. We are able to break down and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 18.79% are justified by taking the suggested risk. Use Bright Minds Mean Deviation of 49.36, risk adjusted performance of 0.1163, and Downside Deviation of 8.54 to evaluate company specific risk that cannot be diversified away. Bright Minds holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -31.72, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bright Minds are expected to decrease by larger amounts. On the other hand, during market turmoil, Bright Minds is expected to outperform it. Use Bright Minds potential upside, and the relationship between the total risk alpha and kurtosis , to analyze future returns on Bright Minds.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Bright Minds Biosciences has insignificant reverse predictability. Overlapping area represents the amount of predictability between Bright Minds time series from 5th of July 2023 to 16th of March 2024 and 16th of March 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bright Minds Biosciences price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Bright Minds price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | -0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 260.55 |
Bright Minds Biosciences lagged returns against current returns
Autocorrelation, which is Bright Minds stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bright Minds' stock expected returns. We can calculate the autocorrelation of Bright Minds returns to help us make a trade decision. For example, suppose you find that Bright Minds has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bright Minds regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bright Minds stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bright Minds stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bright Minds stock over time.
Current vs Lagged Prices |
| Timeline |
Bright Minds Lagged Returns
When evaluating Bright Minds' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bright Minds stock have on its future price. Bright Minds autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bright Minds autocorrelation shows the relationship between Bright Minds stock current value and its past values and can show if there is a momentum factor associated with investing in Bright Minds Biosciences.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:Check out Bright Minds Correlation, Bright Minds Volatility and Bright Minds Alpha and Beta module to complement your research on Bright Minds. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Bright Minds technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.